Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
3.520
+0.180 (5.39%)
At close: Jun 26, 2026, 4:00 PM EDT
3.519
-0.001 (-0.02%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Recursion Pharmaceuticals Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Recursion Pharmaceuticals stock have an average target of 7.38, with a low estimate of 5.50 and a high estimate of 10. The average target predicts an increase of 109.66% from the current stock price of 3.52.
Analyst Consensus: Hold
* Price targets were last updated on May 14, 2026.
Analyst Ratings
The average analyst rating for Recursion Pharmaceuticals stock from 8 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 5 | 5 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $5 → $5.5 | Hold | Maintains | $5 → $5.5 | +56.25% | May 14, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Maintains $6 | Hold | Maintains | $6 | +70.45% | May 13, 2026 |
| Needham | Needham | Buy Reiterates $8 | Buy | Reiterates | $8 | +127.27% | May 7, 2026 |
| TD Cowen | TD Cowen | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 6, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $11 → $10 | Buy | Maintains | $11 → $10 | +184.09% | Apr 30, 2026 |
Financial Forecast
Revenue This Year
66.51M
from 74.68M
Decreased by -10.94%
Revenue Next Year
111.59M
from 66.51M
Increased by 67.78%
EPS This Year
-0.92
from -1.44
EPS Next Year
-0.88
from -0.92
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 86.5M | 320.0M | |
| Avg | 66.5M | 111.6M | |
| Low | 42.5M | 20.7M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 15.8% | 381.1% | |
| Avg | -10.9% | 67.8% | |
| Low | -43.1% | -68.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -0.92 | -0.88 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.